SEARCH · Search PubMed

Results for “PANTOTHENIC ACID”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

SourceResearch connectionFrom yearThrough year

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,549 records · Page 86Linked to original sources

PubMed1957

NUTRITION and bacterial infection.

Explore the source record for details and available documents.

Bacterial Infections↗

PubMed1958

Inhibition of enzymatic synthesis of pantothenate by 2,3-dichloroisobutyrate.

The investigations reported here have shown that 2,3-dichloroisobuty-rate is uncompetitive with beta-alanine and competitive with pantoate for a site on the enzyme of pantothenate synthesis. The enzyme dissociation constant of the inhibitor was comparable to that of the competitive substrate.

Butyrates↗

PubMed1971

Attempts to map a process evolution of peptide biosynthesis.

Explore the source record for details and available documents.

Adenosine Triphosphate↗

PubMed1971

Nutritional requirements of Arizona, Citrobacter, and Providencia.

The nutritional requirements of Arizona, Citrobacter, and Providencia are compared, and chemically defined media in which these organisms may be grown are reported.

Amino Acids↗

PubMed1959

Studies on the nutritional requirements of the fusobacteria. II. Requirements for pantothenate and purines.

Explore the source record for details and available documents.

Fusobacteria↗

PubMed1964

UTILIZATION OF L AND D ISOMERS OF PANTOTHENATE AND PANTOATE FOR MICROBIAL GROWTH.

Explore the source record for details and available documents.

Acetobacter↗

PubMed1972

Malnutrition and peripheral neuropathies.

Explore the source record for details and available documents.

Alcoholism↗

PubMed1990

Synthesis of valproyl-2-pyrrolidinone and its evaluation as a cognitive drug with the ability to modulate acidic amino acids in the brain.

A new pyrrolidinone derivative, valproyl-2-pyrrolidinone (VP), was synthesized, followed by evaluation as a cognitive drug. VP gave rise to a significant protective effect against cerebral anoxia together with a potent prolongation of latency time for the reversal of scopolamine induced transient disruption of the memory of a passive avoidance response in rats. The quantitative experiment using HPLC demonstrated a significant reduction of hippocampal aspartate (Asp) and glutamate (Glu) following the intraperitoneal administration of VP at a dose of 300 mg/kg.

Administration, Oral↗

PubMed1952